Literature DB >> 16461067

Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis--setting the record straight.

Shawn E Cowper, Richard Bucala, Philip E Leboit.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16461067     DOI： 10.1016/j.semarthrit.2005.09.005

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN： 0049-0172            Impact factor:   5.532


× No keyword cloud information.
  17 in total

1.  [Nephrogenic systemic fibrosis. Medical detective work in the 21st century].

Authors:  B Manger
Journal:  Z Rheumatol       Date:  2007-10       Impact factor: 1.372

Review 2.  Safety issues related to intravenous contrast agent use in magnetic resonance imaging.

Authors:  Skorn Ponrartana; Michael M Moore; Sherwin S Chan; Teresa Victoria; Jonathan R Dillman; Govind B Chavhan
Journal:  Pediatr Radiol       Date:  2021-04-19

Review 3.  Nephrogenic systemic fibrosis in liver disease: a systematic review.

Authors:  Sameer M Mazhar; Masoud Shiehmorteza; Chad A Kohl; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2009-12       Impact factor: 4.813

4.  Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report.

Authors:  Beatrice Nardone; Elise Saddleton; Anne E Laumann; Beatrice J Edwards; Dennis W Raisch; June M McKoy; Steven M Belknap; Christian Bull; Anand Haryani; Shawn E Cowper; Ali K Abu-Alfa; Frank H Miller; Victoria Godinez-Puig; Vikas R Dharnidharka; Dennis P West
Journal:  Pediatr Radiol       Date:  2013-09-21

5.  Is it time to relax nephrogenic systemic fibrosis guidelines and safely offer magnetic resonance imaging to more patients?

Authors:  Saif Al-Chalabi; Constantina Chrysochou; Philip A Kalra
Journal:  Quant Imaging Med Surg       Date:  2019-11

Review 6.  Nephrogenic systemic fibrosis: an update.

Authors:  Shawn E Cowper; Philip J Boyer
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

Review 7.  Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus.

Authors:  Joel Garcia; Stephen Z Liu; Angelique Y Louie
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2017-11-28       Impact factor: 4.226

8.  Involvement of the renin-angiotensin system in the development of nephrogenic systemic fibrosis-like lesions in the RenTag mouse model.

Authors:  Sandra Sexton; Ryan Tulowitzki; Craig A Jones; Silvi Shah; George Hajduczok; Kenneth W Gross; Mandip Panesar
Journal:  Clin Exp Nephrol       Date:  2015-07-03       Impact factor: 2.801

9.  Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease.

Authors:  Josef A Schroeder; Christian Weingart; Brigitte Coras; Ingrid Hausser; Stephan Reinhold; Matthias Mack; Volker Seybold; Thomas Vogt; Bernhard Banas; Ferdinand Hofstaedter; Bernhard K Krämer
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 8.237

Review 10.  Nephrogenic systemic fibrosis: an epidemic of gadolinium toxicity.

Authors:  Derrick J Todd; Jonathan Kay
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.